PureTech Health PLC
PRTC19.000USD
-0.089-0.47%
Horário de mercado （ET）Cotações atrasadas em 15 min
4.55BValor de mercado
--P/L TTM
Mais detalhes de PureTech Health PLC Empresa
PureTech Health plc is a clinical stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company's R&D engine has resulted in the development of around 29 therapeutics and therapeutic candidates, including two that have received both United States Food and Drug Administration (FDA) clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. Its product candidates include LYT-100, LYT-200, SPT-300, SPT-310 and SPT-320. LYT-100 (deupirfenidone) is being developed internally by the Company for the treatment of idiopathic pulmonary fibrosis (IPF). LYT-200 is being developed for the treatment of hematological malignancies, such as acute myeloid leukemia and high-risk myelodysplastic syndromes, as well as locally advanced/metastatic solid tumors. SPT-300 is an oral prodrug of allopregnanolone, which is being advanced for the treatment of anxious depression.
Informações da empresa
Código da empresaPRTC
Nome da EmpresaPureTech Health PLC
Data de listagemJun 19, 2015
CEOMr. Robert (Rob) Lyne
Número de funcionários56
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 19
Endereço6 Tide Street
CidadeBOSTON
Bolsa de valoresLondon Stock Exchange
PaísUnited States of America
Código postal02210
Telefone16174822333
Sitehttps://puretechhealth.com/
Código da empresaPRTC
Data de listagemJun 19, 2015
CEOMr. Robert (Rob) Lyne
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kiran Mazumdar-Shaw
Ms. Kiran Mazumdar-Shaw
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Sharon Barber-lui
Ms. Sharon Barber-lui
Interim Independent Non-Executive Chairman of the Board
Interim Independent Non-Executive Chairman of the Board
--
--
Dr. Michele A. M. Holcomb, Ph.D.
Dr. Michele A. M. Holcomb, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Langer (Robert S Jr)
Langer (Robert S Jr)
Co-Founder, Non-Executive Director
Co-Founder, Non-Executive Director
--
--
Dr. John L. Lamattina, Ph.D.
Dr. John L. Lamattina, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Eric Elenko, Ph.D.
Dr. Eric Elenko, Ph.D.
President, Director
President, Director
--
--
Mr. Robert (Rob) Lyne
Mr. Robert (Rob) Lyne
Interim Chief Executive Officer
Interim Chief Executive Officer
--
--
Dr. Charles H. Sherwood, Ph.D.
Dr. Charles H. Sherwood, Ph.D.
General Counsel, Company Secretary
General Counsel, Company Secretary
--
--
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kiran Mazumdar-Shaw
Ms. Kiran Mazumdar-Shaw
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Sharon Barber-lui
Ms. Sharon Barber-lui
Interim Independent Non-Executive Chairman of the Board
Interim Independent Non-Executive Chairman of the Board
--
--
Dr. Michele A. M. Holcomb, Ph.D.
Dr. Michele A. M. Holcomb, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Langer (Robert S Jr)
Langer (Robert S Jr)
Co-Founder, Non-Executive Director
Co-Founder, Non-Executive Director
--
--
Dr. John L. Lamattina, Ph.D.
Dr. John L. Lamattina, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Eric Elenko, Ph.D.
Dr. Eric Elenko, Ph.D.
President, Director
President, Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: seg, 2 de jun
Atualizado em: seg, 2 de jun
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Birch Hill Investment Advisors LLC
1.01%
Millennium Management LLC
0.19%
Pentwater Capital Management LP
0.14%
Portolan Capital Management, L.L.C.
0.05%
Other
98.62%
Investidores
Investidores
Proporção
Birch Hill Investment Advisors LLC
1.01%
Millennium Management LLC
0.19%
Pentwater Capital Management LP
0.14%
Portolan Capital Management, L.L.C.
0.05%
Other
98.62%
Tipos de investidores
Investidores
Proporção
Investment Advisor
1.26%
Hedge Fund
0.33%
Investment Advisor/Hedge Fund
0.05%
Other
98.36%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
15
335.52K
1.39%
-63.86K
2025Q1
14
393.56K
1.64%
-4.75K
2024Q4
14
374.87K
1.56%
+317.90K
2024Q3
13
30.04K
0.13%
-317.21K
2024Q2
12
323.23K
1.35%
+280.87K
2024Q1
9
25.15K
0.09%
-3.71K
2023Q4
10
11.40K
0.04%
-82.93K
2023Q3
12
84.27K
0.31%
-16.31K
2023Q2
11
83.51K
0.30%
-16.43K
2023Q1
13
82.93K
0.30%
-317.41K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Birch Hill Investment Advisors LLC
302.00K
1.25%
--
--
Mar 31, 2025
Millennium Management LLC
44.91K
0.19%
-353.00
-0.78%
Mar 31, 2025
Pentwater Capital Management LP
33.56K
0.14%
+9.45K
+39.19%
Mar 31, 2025
Portolan Capital Management, L.L.C.
11.88K
0.05%
+11.88K
--
Mar 31, 2025
Fidelity Management & Research Company LLC
1.28K
0.01%
--
--
May 31, 2025
Geode Capital Management, L.L.C.
770.00
0%
--
--
May 31, 2025
Dimensional Fund Advisors, L.P.
316.00
0%
-208.00
-39.69%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
100.00
0%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
20.00
0%
-1.88K
-98.95%
Mar 31, 2025
Dimensional Fund Advisors, Ltd.
--
0%
-196.00
-100.00%
Jan 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
